News Archive

CAR T-cell therapy effective for relapsed mantle cell lymphoma patients
A one-year follow-up study led by The University of Texas MD Anderson Cancer Center revealed a majority of patients with mantle cell lymphoma resistant to prior therapies may benefit from treatment with CD19-targeting chimeric antigen receptor (CAR) T-cell therapy.
 09:09 - 05/04/2020 - Comments : 0More >>
Decoy ACE2 receptors could be promising COVID-19 infection-preventing drug
Collaborative research has revealed a drug candidate that could inhibit the SARS-CoV-2 virus causing the COVID-19 pandemic infecting cells through Spike (S) proteins binding to the human angiotensin converting enzyme (ACE2).
 09:08 - 05/04/2020 - Comments : 0More >>

2 3 4 5 6 7 8 9 10 Next Page >>